BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 7150905)

  • 1. Comparison of iopamidol with three other contrast media in orbital venography/cavernous sinography.
    Macpherson P
    Br J Radiol; 1982 Jul; 55(655):539-40. PubMed ID: 7150905
    [No Abstract]   [Full Text] [Related]  

  • 2. Contrast agent induced thrombophlebitis following leg phlebography: iopamidol versus meglumine iothalamate.
    Lea Thomas M; Keeling FP; Piaggio RB; Treweeke PS
    Br J Radiol; 1984 Mar; 57(675):205-7. PubMed ID: 6365232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of arachnoiditis from experimental nonionic contrast media.
    Haughton VM; Ho KC
    Radiology; 1980 Aug; 136(2):395-7. PubMed ID: 6773100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of tri-iodoisophthaldiamide with meglumine lothalamate in phlebography of the leg.
    Thomas ML; Briggs GM
    AJR Am J Roentgenol; 1982 Apr; 138(4):725-7. PubMed ID: 7039276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iopamidol compared with Conray in peripheral angiography.
    Wojciechowski J; Johansson R; Björk L
    Acta Radiol Diagn (Stockh); 1982; 23(6):549-52. PubMed ID: 6763456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of the side effects of urographic contrast media (iothalamate, diatrizoate, iodamide, iopamidol) within the scope of a CT study].
    Stellamor K; Hruby W; Assinger S; Luckner H
    Radiologe; 1984 Oct; 24(10):488-90. PubMed ID: 6505221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of contrast media in cerebral angiography: iopamidol vs. methylglucamine iothalamate.
    Bird CR; Drayer BP; Velaj R; Triolo PJ; Allen S; Bates M; Yeates AE; Heinz ER; Osborne DR
    AJNR Am J Neuroradiol; 1984; 5(6):801-3. PubMed ID: 6437183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of ionic and nonionic contrast media on the sickling phenomenon.
    Rao VM; Rao AK; Steiner RM; Burka ER; Grainger RG; Ballas SK
    Radiology; 1982 Jul; 144(2):291-3. PubMed ID: 7089282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The symptomatic complications of iopamidol (Niopam) and metrizamide (Amipaque) following lumbar radiculography.
    Stoddart PG; Watt I
    Br J Radiol; 1984 Apr; 57(676):349-50. PubMed ID: 6704672
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical cardiovascular experiences with iopamidol: a new non-ionic contrast medium.
    Partridge JB; Robinson PJ; Turnbull CM; Stoker JB; Boyle RM; Morrison GW
    Clin Radiol; 1981 Jul; 32(4):451-5. PubMed ID: 6972848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iopamidol vs. metrizamide myelography: clinical comparison of side effects.
    Trevisan C; Malaguti C; Manfredini M; Tampieri D
    AJNR Am J Neuroradiol; 1983; 4(3):306-8. PubMed ID: 6410728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of platelet function by contrast media: iopamidol and ioxaglate versus iothalamate. Work in progress.
    Rao AK; Rao VM; Willis J; Beckett C; Steiner RM
    Radiology; 1985 Aug; 156(2):311-3. PubMed ID: 4011893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adverse reactions during ascending cervical myelography using iopamidol and metrizamide--a double-blind study].
    Bockenheimer S; Eichenlaub H
    Rontgenpraxis; 1986 May; 39(5):171-4. PubMed ID: 3523789
    [No Abstract]   [Full Text] [Related]  

  • 14. Adverse effects of water-soluble contrast media in myelography, cisternography and ventriculography. A review with special reference to metrizamide.
    Skalpe IO
    Acta Radiol Suppl; 1977; 355():359-70. PubMed ID: 400906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical comparison of metrizamide and iopamidol for myelography.
    Turski PA; Sackett JF; Gentry LR; Strother CM; Matozzi F
    AJNR Am J Neuroradiol; 1983; 4(3):309-11. PubMed ID: 6410729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemodynamic response to opacification of the left ventricle. Comparative study of 3 contrast media with different structures].
    Petitier H; Crochet D; Bizais Y; de Laguerenne J; Grossetête R; Delumeau J
    Ann Radiol (Paris); 1983 Dec; 26(8 Pt 2):753-7. PubMed ID: 6670836
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of radiographic quality and adverse reactions in myelography with iopamidol and metrizamide.
    Bannon KR; Braun IF; Pinto RS; Manuell M; Sudilovsky A; Kricheff II
    AJNR Am J Neuroradiol; 1983; 4(3):312-3. PubMed ID: 6410730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative neurotoxicity of angiographic contrast media.
    Velaj R; Drayer B; Albright R; Fram E
    Neurology; 1985 Sep; 35(9):1290-8. PubMed ID: 3927186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adverse reactions to high osmolarity contrast media. A comparative-prospective study].
    Urrutia M; Macharaviaya A; Rodríguez R
    Rev Med Panama; 1994 Jan; 19(1):19-26. PubMed ID: 7938712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arachnoiditis from myelography with iopamidol, metrizamide, and iocarmate compared in the animal model.
    Haughton VM; Ho KC
    Invest Radiol; 1980; 15(6 Suppl):S267. PubMed ID: 7203934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.